MedPath

Fecal microbiota transplantation for eradication of Vancomycin-Resistant Enterococci

Conditions
Vancomycin-resistant Enterococci carriageAntibiotic resistanceDragerschap vancomycine-resistente Enterococ Antibiotica resistentie
Registration Number
NL-OMON25381
Lead Sponsor
niversity Medical Center Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Adult patients (≥18 years old at date of inclusion)

- Ability to provide informed consent

Exclusion Criteria

- Difficult / impossible follow-up

- Pregnancy or planned pregnancy or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint will be intestinal carriage of VRE (absence/presence by stool culture of VRE) 6 months / 170 - 185 days after intervention.
Secondary Outcome Measures
NameTimeMethod
The secondary endpoint will be intestinal carriage of VRE (absence/presence by stool culture of VRE) 12 months / 355 - 375 days after intervention.
© Copyright 2025. All Rights Reserved by MedPath